Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Coutant

Showing results (441-450 of 835) with videos related to

Pageof 84
Sort By:
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|April 16, 2018
Laparoscopic adjustable gastric banding in adolescents with severe obesity: Psychological aspects, decision makers of surgery, and 2-year outcomes. A case seriesE Riquin, F Schmitt, N Bouhours-Nouet, et al.
Clinical Therapeutics|September 9, 2020
Pharmacokinetic and Glucodynamic Responses of Ultra Rapid Lispro vs Lispro Across a Clinically Relevant Range of Subcutaneous Doses in Healthy SubjectsJennifer Leohr, Mary Anne Dellva, Elizabeth LaBell, et al.
EJNMMI Research|July 4, 2024
Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancerNeree Payan, Benoit Presles, Charles Coutant, et al.
Diabetes Care|March 26, 2026
Ultrarapid Lispro (Lyumjev) Has an Improved Pharmacokinetic Profile for Exercise Compared With Humalog, Resulting in Less Exercise-Associated Hypoglycemia in Adults With Type 1 Diabetes on Open-Loop Continuous Subcutaneous Insulin InfusionJennifer K Leohr, Alexander Abitbol, Lauren V Turner, et al.
Clinical Genetics|July 11, 2019
Confirmation that variants in TTI2 are responsible for autosomal recessive intellectual disabilityAlban Ziegler, Patricia Bader, Kirsty McWalter, et al.
Clinical Endocrinology|December 7, 2010
A new compound heterozygous for c.886C>T/c.2206C>T [p.R277X/p.Q717X] mutations in the thyroglobulin gene as a cause of foetal goitrous hypothyroidismCintia E Citterio, Regis Coutant, Stephanie Rouleau, et al.
Preventive Medicine Reports|June 9, 2023
Impact of Covid-19 on breast cancer stage at discovery, and time to treatment in Cote d'Or, FranceClémence Feron Agbo, Emerline Assogba, Aurélie Bertaut, et al.
JPGN Reports|May 18, 2023
Factors Associated With Weight Loss After Laparoscopic Adjustable Gastric Banding in Adolescents With Severe ObesityLucie Levaillant, Mathieu Levaillant, Nathalie Sfeir, et al.
Environmental Health Perspectives|February 20, 2016
In Vitro Effects of the Endocrine Disruptor p,p'-DDT on Human Follitropin ReceptorMathilde Munier, Julie Grouleff, Louis Gourdin, et al.
Clinical Pharmacology in Drug Development|September 24, 2017
LY2963016 Insulin Glargine and Insulin Glargine (Lantus) Produce Comparable Pharmacokinetics and Pharmacodynamics at Two Dose LevelsXin Zhang, Eric Chen Quin Lam, Mary E Seger, et al.
Pageof 84

Showing results (441-450 of 835) with videos related to

Sort By:
Pageof 84
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|April 16, 2018
Laparoscopic adjustable gastric banding in adolescents with severe obesity: Psychological aspects, decision makers of surgery, and 2-year outcomes. A case seriesE Riquin, F Schmitt, N Bouhours-Nouet, et al.
Clinical Therapeutics|September 9, 2020
Pharmacokinetic and Glucodynamic Responses of Ultra Rapid Lispro vs Lispro Across a Clinically Relevant Range of Subcutaneous Doses in Healthy SubjectsJennifer Leohr, Mary Anne Dellva, Elizabeth LaBell, et al.
EJNMMI Research|July 4, 2024
Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancerNeree Payan, Benoit Presles, Charles Coutant, et al.
Diabetes Care|March 26, 2026
Ultrarapid Lispro (Lyumjev) Has an Improved Pharmacokinetic Profile for Exercise Compared With Humalog, Resulting in Less Exercise-Associated Hypoglycemia in Adults With Type 1 Diabetes on Open-Loop Continuous Subcutaneous Insulin InfusionJennifer K Leohr, Alexander Abitbol, Lauren V Turner, et al.
Clinical Genetics|July 11, 2019
Confirmation that variants in TTI2 are responsible for autosomal recessive intellectual disabilityAlban Ziegler, Patricia Bader, Kirsty McWalter, et al.
Clinical Endocrinology|December 7, 2010
A new compound heterozygous for c.886C>T/c.2206C>T [p.R277X/p.Q717X] mutations in the thyroglobulin gene as a cause of foetal goitrous hypothyroidismCintia E Citterio, Regis Coutant, Stephanie Rouleau, et al.
Preventive Medicine Reports|June 9, 2023
Impact of Covid-19 on breast cancer stage at discovery, and time to treatment in Cote d'Or, FranceClémence Feron Agbo, Emerline Assogba, Aurélie Bertaut, et al.
JPGN Reports|May 18, 2023
Factors Associated With Weight Loss After Laparoscopic Adjustable Gastric Banding in Adolescents With Severe ObesityLucie Levaillant, Mathieu Levaillant, Nathalie Sfeir, et al.
Environmental Health Perspectives|February 20, 2016
In Vitro Effects of the Endocrine Disruptor p,p'-DDT on Human Follitropin ReceptorMathilde Munier, Julie Grouleff, Louis Gourdin, et al.
Clinical Pharmacology in Drug Development|September 24, 2017
LY2963016 Insulin Glargine and Insulin Glargine (Lantus) Produce Comparable Pharmacokinetics and Pharmacodynamics at Two Dose LevelsXin Zhang, Eric Chen Quin Lam, Mary E Seger, et al.
Pageof 84